While GLP-1 medications effectively suppress appetite, they don’t address the underlying behavioral patterns that lead to weight gain. The Journal of Clinical Endocrinology & Metabolism reports that without behavioral changes, most patients regain 66% of their lost weight within a year of stopping medication.
Some of the most consistent challenges of these medications are:
Fresh Tri targets the behavioral foundations of weight management. Our Iterative Mindset Method™ works with the brain’s natural habit-forming mechanisms, eliminating the concept of failure that triggers the habenula.
This brain science-based approach offers several advantages:
For GLP-1 users, Fresh Tri serves as the perfect complement, helping maximize results and prepare for medication reduction. For others, it offers a sustainable alternative addressing the root causes of weight management challenges.
Organizations implementing Fresh Tri have documented significant improvements in employee health metrics without the high costs of GLP-1 medications. The American Diabetes Association recognizes that sustainable behavioral approaches should be the foundation of weight management programs, with medications serving as adjuncts rather than primary interventions.
To learn how Fresh Tri can help your organization reduce GLP-1 medication costs while improving sustainable health outcomes, visit our How It Works page and discover why blaming the brain, not your employees, is the key to lasting weight management success.
Made with 😍 in
California, USA.
Made with 😍 in California, USA.